US Stock MarketDetailed Quotes

Aclaris Therapeutics (ACRS)

Watchlist
  • 4.300
  • -0.250-5.49%
Close Apr 24 15:59 ET
  • 4.300
  • 0.0000.00%
Post 20:01 ET
600.55MMarket Cap-8.11P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics (ACRS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-58.19%7.83M
-85.94%1.3M
-24.09%3.3M
-35.76%1.78M
-39.32%1.46M
-40.09%18.72M
-47.58%9.21M
-53.18%4.35M
47.99%2.77M
-5.14%2.4M
Operating revenue
-58.19%7.83M
-85.94%1.3M
-24.09%3.3M
-35.76%1.78M
-39.32%1.46M
-40.09%18.72M
-47.58%9.21M
-53.18%4.35M
47.99%2.77M
-5.14%2.4M
Cost of revenue
-52.88%7.28M
-84.21%1.47M
1.70%2.45M
-3.09%1.85M
-17.61%1.52M
-14.51%15.46M
44.70%9.3M
-70.61%2.41M
19.91%1.91M
-1.55%1.84M
Gross profit
-83.38%542K
-93.33%-174K
-56.14%850K
-108.52%-73K
-110.93%-61K
-75.23%3.26M
-100.81%-90K
77.80%1.94M
209.39%857K
-15.33%558K
Operating expense
31.42%70.8M
60.92%20.86M
60.36%17.18M
17.49%15.87M
1.20%16.89M
-58.39%53.88M
-62.82%12.96M
-65.07%10.72M
-58.52%13.51M
-46.81%16.69M
Selling and administrative expenses
-1.04%21.97M
12.56%5.58M
-13.83%4.87M
13.34%5.39M
-10.30%6.14M
-28.60%22.2M
-39.69%4.95M
-16.84%5.65M
-34.87%4.75M
-22.14%6.84M
-General and administrative expense
-1.04%21.97M
12.56%5.58M
-13.83%4.87M
13.34%5.39M
-10.30%6.14M
-28.60%22.2M
-39.69%4.95M
-16.84%5.65M
-34.87%4.75M
-22.14%6.84M
Research and development costs
56.75%52.65M
83.74%16.58M
118.74%13.03M
30.71%11.45M
17.66%11.58M
-65.86%33.59M
-66.13%9.03M
-75.05%5.96M
-65.35%8.76M
-56.41%9.85M
Other operating expenses
-99.32%-3.82M
-27.94%-1.31M
19.91%-716K
---961K
---833K
---1.91M
---1.02M
---894K
----
----
Operating profit
-38.82%-70.26M
-61.14%-21.03M
-86.09%-16.33M
-26.02%-15.95M
-5.08%-16.95M
56.49%-50.61M
44.98%-13.05M
70.33%-8.78M
60.82%-12.65M
47.49%-16.13M
Net non-operating interest income expense
-3.97%7.64M
-22.30%1.63M
-8.64%1.82M
8.03%2.02M
8.84%2.17M
7.95M
2.1M
-14.03%1.99M
1.87M
1.99M
Non-operating interest income
-3.97%7.64M
-22.30%1.63M
-8.64%1.82M
8.03%2.02M
8.84%2.17M
--7.95M
--2.1M
-14.03%1.99M
--1.87M
--1.99M
Other net income (expense)
97.43%-2.3M
99.53%-400K
87.50%-100K
-650.00%-1.5M
89.29%-300K
-425.51%-89.41M
-403.78%-85.61M
59.86%-800K
-107.34%-200K
-209.46%-2.8M
Special income (charges)
97.43%-2.3M
99.53%-400K
87.50%-100K
-650.00%-1.5M
89.29%-300K
-571.62%-89.41M
-535.18%-85.61M
59.86%-800K
-141.75%-200K
-450.00%-2.8M
-Less：Restructuring and merger&acquisition
-8.00%2.3M
130.77%400K
-87.50%100K
650.00%1.5M
-89.29%300K
109.29%2.5M
95.06%-1.3M
-52.94%800K
113.33%200K
450.00%2.8M
-Less:Other special charges
----
----
----
----
----
1,210.98%86.91M
----
----
----
----
-Write off
----
----
----
----
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
----
----
-19.91%716K
-48.55%961K
-58.14%833K
15.96%9.87M
--8.97M
--894K
-16.83%1.87M
13.20%1.99M
Income before tax
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-48.64%-132.07M
-5,096.56%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
Income tax
0
Net income
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
Net income continuous Operations
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
Minority interest income
Net income attributable to the parent company
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
Basic earnings per share
69.01%-0.53
84.16%-0.16
-9.09%-0.12
13.33%-0.13
50.00%-0.12
-34.65%-1.71
-4,950.00%-1.01
73.17%-0.11
64.29%-0.15
42.86%-0.24
Diluted earnings per share
69.01%-0.53
84.16%-0.16
-9.09%-0.12
13.33%-0.13
50.00%-0.12
-34.65%-1.71
-4,950.00%-1.01
73.17%-0.11
64.29%-0.15
42.86%-0.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -58.19%7.83M-85.94%1.3M-24.09%3.3M-35.76%1.78M-39.32%1.46M-40.09%18.72M-47.58%9.21M-53.18%4.35M47.99%2.77M-5.14%2.4M
Operating revenue -58.19%7.83M-85.94%1.3M-24.09%3.3M-35.76%1.78M-39.32%1.46M-40.09%18.72M-47.58%9.21M-53.18%4.35M47.99%2.77M-5.14%2.4M
Cost of revenue -52.88%7.28M-84.21%1.47M1.70%2.45M-3.09%1.85M-17.61%1.52M-14.51%15.46M44.70%9.3M-70.61%2.41M19.91%1.91M-1.55%1.84M
Gross profit -83.38%542K-93.33%-174K-56.14%850K-108.52%-73K-110.93%-61K-75.23%3.26M-100.81%-90K77.80%1.94M209.39%857K-15.33%558K
Operating expense 31.42%70.8M60.92%20.86M60.36%17.18M17.49%15.87M1.20%16.89M-58.39%53.88M-62.82%12.96M-65.07%10.72M-58.52%13.51M-46.81%16.69M
Selling and administrative expenses -1.04%21.97M12.56%5.58M-13.83%4.87M13.34%5.39M-10.30%6.14M-28.60%22.2M-39.69%4.95M-16.84%5.65M-34.87%4.75M-22.14%6.84M
-General and administrative expense -1.04%21.97M12.56%5.58M-13.83%4.87M13.34%5.39M-10.30%6.14M-28.60%22.2M-39.69%4.95M-16.84%5.65M-34.87%4.75M-22.14%6.84M
Research and development costs 56.75%52.65M83.74%16.58M118.74%13.03M30.71%11.45M17.66%11.58M-65.86%33.59M-66.13%9.03M-75.05%5.96M-65.35%8.76M-56.41%9.85M
Other operating expenses -99.32%-3.82M-27.94%-1.31M19.91%-716K---961K---833K---1.91M---1.02M---894K--------
Operating profit -38.82%-70.26M-61.14%-21.03M-86.09%-16.33M-26.02%-15.95M-5.08%-16.95M56.49%-50.61M44.98%-13.05M70.33%-8.78M60.82%-12.65M47.49%-16.13M
Net non-operating interest income expense -3.97%7.64M-22.30%1.63M-8.64%1.82M8.03%2.02M8.84%2.17M7.95M2.1M-14.03%1.99M1.87M1.99M
Non-operating interest income -3.97%7.64M-22.30%1.63M-8.64%1.82M8.03%2.02M8.84%2.17M--7.95M--2.1M-14.03%1.99M--1.87M--1.99M
Other net income (expense) 97.43%-2.3M99.53%-400K87.50%-100K-650.00%-1.5M89.29%-300K-425.51%-89.41M-403.78%-85.61M59.86%-800K-107.34%-200K-209.46%-2.8M
Special income (charges) 97.43%-2.3M99.53%-400K87.50%-100K-650.00%-1.5M89.29%-300K-571.62%-89.41M-535.18%-85.61M59.86%-800K-141.75%-200K-450.00%-2.8M
-Less：Restructuring and merger&acquisition -8.00%2.3M130.77%400K-87.50%100K650.00%1.5M-89.29%300K109.29%2.5M95.06%-1.3M-52.94%800K113.33%200K450.00%2.8M
-Less:Other special charges --------------------1,210.98%86.91M----------------
-Write off ----------------------0--0--0--0----
Other non- operating income (expenses) ---------19.91%716K-48.55%961K-58.14%833K15.96%9.87M--8.97M--894K-16.83%1.87M13.20%1.99M
Income before tax 50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-48.64%-132.07M-5,096.56%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M
Income tax 0
Net income 50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M
Net income continuous Operations 50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M
Minority interest income
Net income attributable to the parent company 50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M
Basic earnings per share 69.01%-0.5384.16%-0.16-9.09%-0.1213.33%-0.1350.00%-0.12-34.65%-1.71-4,950.00%-1.0173.17%-0.1164.29%-0.1542.86%-0.24
Diluted earnings per share 69.01%-0.5384.16%-0.16-9.09%-0.1213.33%-0.1350.00%-0.12-34.65%-1.71-4,950.00%-1.0173.17%-0.1164.29%-0.1542.86%-0.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -